Therapy-related leukaemias with balanced translocations can arise from pre-existing clonal haematopoiesis
Open Access
- 5 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 35 (8), 2407-2411
- https://doi.org/10.1038/s41375-021-01150-3
Abstract
No abstract availableFunding Information
- DH | National Institute for Health Research (RP-PG-0108-10093)
- Cancer Research UK (CRUK/19/013)
This publication has 15 references indexed in Scilit:
- Genomic Classification and Prognosis in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2016
- Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaLeukemia, 2016
- Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AMLBlood, 2016
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaNature, 2014
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemiaNature, 2014
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaThe New England Journal of Medicine, 2013
- Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemiaBlood, 2010
- DNA Topoisomerase II in Therapy-Related Acute Promyelocytic LeukemiaThe New England Journal of Medicine, 2005
- Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesBlood, 2003
- Balanced chromosome abnormalities inv(16) and t(15;17) in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†Genes, Chromosomes and Cancer, 2002